Tuberculosis Trends, Disparities, and Forecasts in the United States: Will the 2035 Elimination Goal Be Met?
Authors:
- Daniyal Ali KhanDKDaniyal Ali Khan
- Syed Ali Tayyeb HasanSHSyed Ali Tayyeb Hasan
- Kantesh KumarKKKantesh Kumar
- Mustafa AmanMAMustafa Aman
- Shahzaib KhanSKShahzaib Khan
- Mahnoor KhanMKMahnoor Khan
- Syed Haider Ali GardeziSGSyed Haider Ali Gardezi
- Ali Bin Abdul JabbarAJAli Bin Abdul Jabbar
- Syed Faisal MahmoodSMSyed Faisal Mahmood
Preprint
- 15 September 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Tuberculosis (TB) remains a US public health concern, with persistent disparities, yet TB-related mortality trends, especially among older adults, remain understudied. Methods This cross-sectional study analysed CDC-WONDER mortality data (1999–2023) and National Notifiable Diseases Surveillance System incidence data (1999–2022) for adults aged ≥ 45 years. TB (ICD-10: A16-A19) incidence rates (IRs), age-adjusted and crude mortality rates (AAMRs, CMRs) were calculated per million population. Trends were analysed using Joinpoint regression, and ARIMA models were used to forecast mortality through 2035 in the context of the US elimination target. Results From 1999–2022, TB IRs declined from 64.3 to 25.0 per million. AAMRs fell from 17.4 to 7.5 between 1999–2023 (AAPC = -3.36%, 95% CI: -3.72 to -2.98). Of 26,341 deaths, 62.5% were male. By 2023, AAMRs in both genders had declined by over half. CMRs decreased across all age groups, with the largest decline in those ≥ 85 years, who also had the highest rates. Asian/Pacific Islander and American Indian/Alaska Native populations consistently had the highest AAMRs, while White individuals had the lowest. All regions except the West showed steady declines. Alaska, Hawaii, California, Mississippi, and Texas had the highest AAMRs. Large metropolitan areas consistently had higher AAMRs. Most deaths were due to respiratory TB, and 65.2% occurred in inpatient hospitals. Forecasting indicated that AAMRs are projected to remain above the US elimination threshold by 2035. Conclusion TB-related mortality in the US has declined over two decades, but recent resurgence and persistent demographic and geographic disparities highlight the need for targeted interventions to achieve elimination.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Racial and Ethnic Disparities in Tuberculosis—the Cost of NeglectJAMA Network Open, 2024
- Prediction of early‐onset colorectal cancer mortality rates in the United States using machine learningCancer Medicine, 2023
- Sex and Gender Differences in Tuberculosis Pathogenesis and Treatment Outcomes2023
- Tuberculosis in older adults: challenges and best practices in the Western Pacific RegionThe Lancet Regional Health - Western Pacific, 2023
- Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19JAMA, 2022
- Epidemiological characteristics and forecasting incidence for patients with breast cancer in Shantou, Southern China: 2006–2017Cancer Medicine, 2021
- Ending tuberculosis by 2030—Pipe dream or reality?International Journal of Infectious Diseases, 2020
- Tuberculosis Transmission or Mortality Among Persons Living with HIV, USA, 2011–2016Journal of Racial and Ethnic Health Disparities, 2020
- Tuberculosis and gender – Factors influencing the risk of tuberculosis among men and women by age groupPulmonology, 2018
- The ratio of older women to men: Historical perspectives and cross-national comparisonsAging Clinical and Experimental Research, 2000